$EXPO
EXPONENT INC Stock $expo

$expo Overview Financials Valuation SEC Filings Company Website

2014 Q2 Form 10-Q Financial Statement

#000114420414029158 Filed on May 09, 2014

Income Statement

Concept	2014 Q2	2014 Q1	2013 Q1
Revenue	$75.96M	$72.80M	$72.66M
YoY Change	0.61%	0.19%	1.02%
Cost Of Revenue	$3.000M	$3.700M	$3.700M
YoY Change	-16.67%	0.0%	-32.73%
Gross Profit	$73.00M	$69.00M	$69.00M
YoY Change	1.53%	0.0%	3.76%
Gross Profit Margin	96.1%	94.78%	94.96%
Selling, General & Admin	$52.60M	$50.20M	$52.00M
YoY Change	9.36%	-3.46%	5.91%
% of Gross Profit	72.05%	72.75%	75.36%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.300M	$1.300M	$1.100M
YoY Change	0.0%	18.18%	0.0%
% of Gross Profit	1.78%	1.88%	1.59%
Operating Expenses	$61.87M	$56.70M	$61.81M
YoY Change	6.83%	-8.27%	2.83%
Operating Profit	$14.09M	$12.30M	$10.85M
YoY Change	-19.89%	13.35%	-8.17%
Interest Expense	$0.00	$0.00	$0.00
YoY Change			-100.0%
% of Operating Profit	0.0%	0.0%	0.0%
Other Income/Expense, Net	$1.271M	$2.300M	$2.654M
YoY Change	87.46%	-13.34%	38.45%
Pretax Income	$15.37M	$14.70M	$13.51M
YoY Change	-15.9%	8.85%	-1.66%
Income Tax	$6.211M	$5.900M	$5.529M
% Of Pretax Income	40.42%	40.14%	40.94%
Net Earnings	$9.154M	$8.700M	$7.976M
YoY Change	-15.62%	9.08%	-2.74%
Net Earnings / Revenue	12.05%	11.95%	10.98%
Basic Earnings Per Share	$0.34		$0.58
Diluted Earnings Per Share	$0.33	$155.9K	$0.56
COMMON SHARES
Basic Shares Outstanding	27.07M shares	13.06M shares	13.67M shares
Diluted Shares Outstanding	27.88M shares		14.13M shares

Balance Sheet

Concept	2014 Q2	2014 Q1	2013 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$137.5M	$156.1M	$111.0M
YoY Change	11.7%	40.63%	7.04%
Cash & Equivalents	$105.6M	$122.9M	$101.5M
Short-Term Investments	$31.80M	$33.20M	$9.500M
Other Short-Term Assets	$27.20M	$18.60M	$15.00M
YoY Change	45.45%	24.0%	17.19%
Inventory
Prepaid Expenses
Receivables	$84.95M	$76.98M	$80.60M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$249.6M	$251.7M	$206.6M
YoY Change	9.43%	21.82%	8.22%
LONG-TERM ASSETS
Property, Plant & Equipment	$28.31M	$28.72M	$28.30M
YoY Change	-1.56%	1.49%	3.42%
Goodwill	$8.607M	$8.607M
YoY Change	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$593.0K	$551.0K	$51.50M
YoY Change	2.24%	-98.93%	6766.67%
Total Long-Term Assets	$92.35M	$92.48M	$88.40M
YoY Change	7.13%	4.62%	15.77%
TOTAL ASSETS
Total Short-Term Assets	$249.6M	$251.7M	$206.6M
Total Long-Term Assets	$92.35M	$92.48M	$88.40M
Total Assets	$342.0M	$344.2M	$295.0M
YoY Change	8.8%	16.67%	10.38%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$12.90M	$2.798M	$7.000M
YoY Change	115.0%	-60.03%	-16.67%
Accrued Expenses	$42.30M	$5.644M	$30.40M
YoY Change	-5.16%	-81.43%	10.95%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$62.40M	$72.15M	$42.80M
YoY Change	7.0%	68.57%	4.71%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$1.250M	$1.181M	$34.00M
YoY Change	13.43%	-96.53%	4668.58%
Total Long-Term Liabilities	$1.250M	$1.181M	$34.00M
YoY Change	13.43%	-96.53%	4668.58%
TOTAL LIABILITIES
Total Short-Term Liabilities	$62.40M	$72.15M	$42.80M
Total Long-Term Liabilities	$1.250M	$1.181M	$34.00M
Total Liabilities	$100.4M	$109.1M	$76.90M
YoY Change	10.22%	41.88%	13.41%
SHAREHOLDERS EQUITY
Retained Earnings	$225.6M	$226.0M
YoY Change	7.13%
Common Stock	$155.7M	$141.3M
YoY Change	12.24%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$139.9M	$132.4M
YoY Change	11.58%
Treasury Stock Shares	3.293M shares	3.363M shares
Shareholders Equity	$241.6M	$235.1M	$218.1M
YoY Change
Total Liabilities & Shareholders Equity	$342.0M	$344.2M	$295.0M
YoY Change	8.8%	16.67%	10.38%

Cashflow Statement

Concept	2014 Q2	2014 Q1	2013 Q1
OPERATING ACTIVITIES
Net Income	$9.154M	$8.700M	$7.976M
YoY Change	-15.62%	9.08%	-2.74%
Depreciation, Depletion And Amortization	$1.300M	$1.300M	$1.100M
YoY Change	0.0%	18.18%	0.0%
Cash From Operating Activities	-$6.100M	$28.00M	-$5.200M
YoY Change	-128.24%	-638.46%	271.69%
INVESTING ACTIVITIES
Capital Expenditures	$915.0K	-$1.600M	$1.959M
YoY Change	-47.47%	-181.67%	51.39%
Acquisitions
YoY Change
Other Investing Activities	$1.100M	-$20.10M	$11.20M
YoY Change	-64.52%	-279.46%
Cash From Investing Activities	$200.0K	-$21.70M	$9.300M
YoY Change	-84.62%	-333.33%	-818.7%
FINANCING ACTIVITIES
Cash Dividend Paid	$3.310M		$1.969M
YoY Change
Common Stock Issuance & Retirement, Net	$6.831M		$11.49M
YoY Change			226.42%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-11.60M	-5.600M	-15.20M
YoY Change	48.72%	-63.16%	336.78%
NET CHANGE
Cash From Operating Activities	-6.100M	28.00M	-5.200M
Cash From Investing Activities	200.0K	-21.70M	9.300M
Cash From Financing Activities	-11.60M	-5.600M	-15.20M
Net Change In Cash	-17.50M	700.0K	-11.10M
YoY Change	-215.89%	-106.31%	79.82%
FREE CASH FLOW
Cash From Operating Activities	-$6.100M	$28.00M	-$5.200M
Capital Expenditures	$915.0K	-$1.600M	$1.959M
Free Cash Flow	-$7.015M	$29.60M	-$7.159M
YoY Change	-135.33%	-513.47%	165.84%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2014Q2	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	72967000	USD
CY2013Q1	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	68992000	USD
CY2014Q2	us-gaap	Reimbursement Revenue ReimbursementRevenue	2995000	USD
CY2013Q1	us-gaap	Reimbursement Revenue ReimbursementRevenue	3668000	USD
CY2014Q2	us-gaap	Revenues Revenues	75962000	USD
CY2013Q1	us-gaap	Revenues Revenues	72660000	USD
CY2014Q2	us-gaap	Labor And Related Expense LaborAndRelatedExpense	48858000	USD
CY2013Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	48562000	USD
CY2014Q2	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	6317000	USD
CY2013Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	6147000	USD
CY2014Q2	us-gaap	Cost Of Reimbursable Expense CostOfReimbursableExpense	2995000	USD
CY2013Q1	us-gaap	Cost Of Reimbursable Expense CostOfReimbursableExpense	3668000	USD
CY2014Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3698000	USD
CY2013Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3432000	USD
CY2014Q2	us-gaap	Operating Expenses OperatingExpenses	61868000	USD
CY2013Q1	us-gaap	Operating Expenses OperatingExpenses	61809000	USD
CY2014Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	14094000	USD
CY2013Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	10851000	USD
CY2014Q2	us-gaap	Investment Income Net InvestmentIncomeNet	44000	USD
CY2013Q1	us-gaap	Investment Income Net InvestmentIncomeNet	45000	USD
CY2014Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1227000	USD
CY2013Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2609000	USD
CY2014Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	15365000	USD
CY2013Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	13505000	USD
CY2014Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6211000	USD
CY2013Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5529000	USD
CY2014Q2	us-gaap	Net Income Loss NetIncomeLoss	9154000	USD
CY2013Q1	us-gaap	Net Income Loss NetIncomeLoss	7976000	USD
CY2014Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.68
CY2013Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.58
CY2014Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.66
CY2013Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.56
CY2014Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13537000	shares
CY2013Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13667000	shares
CY2014Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13940000	shares
CY2013Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14125000	shares
CY2014Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	52000	USD
CY2013Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-461000	USD
CY2014Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	14000	USD
CY2013Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-12000	USD
CY2014Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	9220000	USD
CY2013Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	7503000	USD
CY2014Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	156103000	USD
CY2014Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	137412000	USD
CY2014	us-gaap	Available For Sale Securities Gross Unrealized Gains AvailableForSaleSecuritiesGrossUnrealizedGains	25000	USD
CY2014Q2	us-gaap	Available For Sale Securities Gross Unrealized Gains AvailableForSaleSecuritiesGrossUnrealizedGains	43000	USD
CY2014	us-gaap	Available For Sale Debt Securities Gross Unrealized Loss AvailableForSaleDebtSecuritiesGrossUnrealizedLoss	9000	USD
CY2014Q2	us-gaap	Available For Sale Debt Securities Gross Unrealized Loss AvailableForSaleDebtSecuritiesGrossUnrealizedLoss	3000	USD
CY2014Q1	expo	Cash Cash Equivalents And Short Term Investments Fair Value Disclosure CashCashEquivalentsAndShortTermInvestmentsFairValueDisclosure	156119000	USD
CY2014Q2	expo	Cash Cash Equivalents And Short Term Investments Fair Value Disclosure CashCashEquivalentsAndShortTermInvestmentsFairValueDisclosure	137452000	USD
CY2014Q2	expo	Available For Sale Securities Short Term Investments Amortized Cost Due In Year One AvailableForSaleSecuritiesShortTermInvestmentsAmortizedCostDueInYearOne	14945000	USD
CY2014Q2	expo	Available For Sale Securities Short Term Investments Amortized Cost Due In Year Two AvailableForSaleSecuritiesShortTermInvestmentsAmortizedCostDueInYearTwo	16846000	USD
CY2014Q2	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	31791000	USD
CY2014Q2	expo	Available For Sale Securities Short Term Investments Estimated Fair Value Due In Year One AvailableForSaleSecuritiesShortTermInvestmentsEstimatedFairValueDueInYearOne	14956000	USD
CY2014Q2	expo	Available For Sale Securities Short Term Investments Estimated Fair Value Due In Year Two AvailableForSaleSecuritiesShortTermInvestmentsEstimatedFairValueDueInYearTwo	16875000	USD
CY2014Q2	us-gaap	Short Term Investments ShortTermInvestments	31831000	USD
CY2014Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	122948000	USD
CY2014Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	105621000	USD
CY2014Q1	us-gaap	Short Term Investments ShortTermInvestments	33171000	USD
CY2014Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	76980000	USD
CY2014Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	84946000	USD
CY2014Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	10450000	USD
CY2014Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	16835000	USD
CY2014Q1	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	8135000	USD
CY2014Q2	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	10408000	USD
CY2014Q1	us-gaap	Assets Current AssetsCurrent	251684000	USD
CY2014Q2	us-gaap	Assets Current AssetsCurrent	249641000	USD
CY2014Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	28721000	USD
CY2014Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	28314000	USD
CY2014Q1	us-gaap	Goodwill Goodwill	8607000	USD
CY2014Q2	us-gaap	Goodwill Goodwill	8607000	USD
CY2014Q1	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	21102000	USD
CY2014Q2	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	22073000	USD
CY2014Q1	us-gaap	Deferred Compensation Plan Assets DeferredCompensationPlanAssets	33501000	USD
CY2014Q2	us-gaap	Deferred Compensation Plan Assets DeferredCompensationPlanAssets	32766000	USD
CY2014Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	6771000	USD
CY2014Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	551000	USD
CY2014Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	593000	USD
CY2014Q1	us-gaap	Assets Assets	344166000	USD
CY2014Q2	us-gaap	Assets Assets	341994000	USD
CY2014Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	8442000	USD
CY2014Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	12862000	USD
CY2014Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	56934000	USD
CY2014Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	42336000	USD
CY2014Q1	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	2332000	USD
CY2014Q2	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	2233000	USD
CY2014Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2014Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2014Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2013Q1	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	229433	shares
CY2014Q2	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	7631000	USD
CY2013Q1	us-gaap	Treasury Stock Reissued At Lower Than Repurchase Price TreasuryStockReissuedAtLowerThanRepurchasePrice	10025000	USD
CY2014Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	7204000	USD
CY2014Q1	us-gaap	Liabilities Current LiabilitiesCurrent	72147000	USD
CY2014Q2	us-gaap	Liabilities Current LiabilitiesCurrent	62402000	USD
CY2014Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1181000	USD
CY2014Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1250000	USD
CY2014Q1	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	33447000	USD
CY2014Q2	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	34516000	USD
CY2014Q1	us-gaap	Liabilities Liabilities	109107000	USD
CY2014Q2	us-gaap	Liabilities Liabilities	100401000	USD
CY2014Q1	us-gaap	Common Stock Value CommonStockValue	16000	USD
CY2014Q2	us-gaap	Common Stock Value CommonStockValue	16000	USD
CY2014Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	141250000	USD
CY2014Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	155690000	USD
CY2014Q1	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	10000	USD
CY2014Q2	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	24000	USD
CY2014Q1	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	99000	USD
CY2014Q2	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	151000	USD
CY2014Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	109000	USD
CY2014Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	175000	USD
CY2014Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	226040000	USD
CY2014Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	225592000	USD
CY2014Q1	us-gaap	Treasury Stock Value TreasuryStockValue	132356000	USD
CY2014Q2	us-gaap	Treasury Stock Value TreasuryStockValue	139880000	USD
CY2014Q1	us-gaap	Stockholders Equity StockholdersEquity	235059000	USD
CY2014Q2	us-gaap	Stockholders Equity StockholdersEquity	241593000	USD
CY2014Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	344166000	USD
CY2014Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	341994000	USD
CY2014Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	2771000	USD
CY2014Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	2753000	USD
CY2014Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2014Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	16427000	shares
CY2014Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	16427000	shares
CY2014Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	3363000	shares
CY2014Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	3293000	shares
CY2014Q2	us-gaap	Income Taxes Paid IncomeTaxesPaid	428000	USD
CY2013Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	623000	USD
CY2014Q2	expo	Vested Restricted Stock Awards Issued To Settle Accrued Bonuses VestedRestrictedStockAwardsIssuedToSettleAccruedBonuses	6008000	USD
CY2013Q1	expo	Vested Restricted Stock Awards Issued To Settle Accrued Bonuses VestedRestrictedStockAwardsIssuedToSettleAccruedBonuses	5807000	USD
CY2014Q2	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	800000	USD
CY2013Q1	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	694000	USD
CY2014Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1322000	USD
CY2013Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1149000	USD
CY2014Q2	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-225000	USD
CY2013Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-79000	USD
CY2014Q2	us-gaap	Increase Decrease In Other Deferred Liability IncreaseDecreaseInOtherDeferredLiability	-99000	USD
CY2013Q1	us-gaap	Increase Decrease In Other Deferred Liability IncreaseDecreaseInOtherDeferredLiability	61000	USD
CY2014Q2	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	249000	USD
CY2013Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	135000	USD
CY2014Q2	us-gaap	Share Based Compensation ShareBasedCompensation	5293000	USD
CY2013Q1	expo	Entity Wide Sales Revenue Major Customer EntityWideSalesRevenueMajorCustomer	0.1	pure
CY2013Q3	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	1945000	USD
CY2014Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.15
CY2013Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.15
CY2014Q2	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	3262000	USD
CY2014Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	1965000	USD
CY2013Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	1969000	USD
CY2013Q1	us-gaap	Share Based Compensation ShareBasedCompensation	5291000	USD
CY2014Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-3324000	USD
CY2013Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1254000	USD
CY2014Q2	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	4499000	USD
CY2013Q1	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	3774000	USD
CY2014Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	8215000	USD
CY2013Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-4674000	USD
CY2014Q2	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	4988000	USD
CY2013Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3121000	USD
CY2014Q2	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	8167000	USD
CY2013Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	240000	USD
CY2014Q2	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-9838000	USD
CY2013Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-15401000	USD
CY2014Q2	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	433000	USD
CY2013Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-1237000	USD
CY2014Q2	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-6120000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-5182000	USD
CY2014Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	915000	USD
CY2013Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1959000	USD
CY2014Q2	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	1140000	USD
CY2013Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	11240000	USD
CY2014Q2	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	225000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	9281000	USD
CY2014Q2	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	4499000	USD
CY2013Q1	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	3774000	USD
CY2014Q2	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	6267000	USD
CY2013Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	6119000	USD
CY2014Q2	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	6831000	USD
CY2013Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	11490000	USD
CY2014Q2	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	329000	USD
CY2013Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	612000	USD
CY2014Q2	us-gaap	Payments Of Dividends PaymentsOfDividends	3310000	USD
CY2013Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	1969000	USD
CY2014Q2	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-11580000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-15192000	USD
CY2014Q2	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	148000	USD
CY2013Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-674000	USD
CY2014Q2	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-17327000	USD
CY2013Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-11767000	USD
CY2014Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	122948000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	113268000	USD
CY2013Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	101501000	USD
CY2014Q2	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	pure
CY2014Q2	dei	Document Type DocumentType	10-Q
CY2014Q2	dei	Amendment Flag AmendmentFlag	false
CY2014Q2	dei	Document Period End Date DocumentPeriodEndDate	2014-04-04
CY2014Q2	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2014
CY2014Q2	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2014Q2	dei	Trading Symbol TradingSymbol	EXPO
CY2014Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	13102801	shares
CY2014Q2	dei	Entity Registrant Name EntityRegistrantName	EXPONENT INC
CY2014Q2	dei	Entity Central Index Key EntityCentralIndexKey	0000851520
CY2014Q2	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--01-02
CY2014Q2	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2006Q2	expo	Authorized Common Stock Shares Limit On Use AuthorizedCommonStockSharesLimitOnUse	40000000	shares
CY2006Q2	expo	Authorized Preferred Stock Shares Limit On Use AuthorizedPreferredStockSharesLimitOnUse	2000000	shares
CY2014Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1271000	USD
CY2013Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2654000	USD
CY2012Q1	us-gaap	Stock Repurchase Program Authorized Amount StockRepurchaseProgramAuthorizedAmount	35000000	USD
CY2013Q1	us-gaap	Stock Repurchase Program Authorized Amount StockRepurchaseProgramAuthorizedAmount	35000000	USD
CY2014Q2	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	102719	shares
CY2013Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	11676000	USD
CY2014Q2	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount	23369000	USD
CY2014Q2	us-gaap	Treasury Stock Reissued At Lower Than Repurchase Price TreasuryStockReissuedAtLowerThanRepurchasePrice	6050000	USD
CY2014Q2	expo	Share Based Compensation Arrangements By Share Based Payment Award Options Expiration Term ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTerm	P10Y
CY2014Q1	expo	Entity Wide Account Receivable Major Customer Percentage EntityWideAccountReceivableMajorCustomerPercentage	0.1	pure
CY2014Q2	expo	Entity Wide Account Receivable Major Customer Percentage EntityWideAccountReceivableMajorCustomerPercentage	0.1	pure
CY2014Q2	expo	Entity Wide Sales Revenue Major Customer EntityWideSalesRevenueMajorCustomer	0.1	pure
CY2014Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.25
CY2013Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.15
CY2014Q2	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.25
CY2013Q2	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.15
CY2013Q3	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.15
CY2014	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	7877000	USD
CY2013Q2	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	1998000	USD

Files In Submission

Name	View Source	Status
0001144204-14-029158-index-headers.html	Edgar Link	pending
0001144204-14-029158-index.html	Edgar Link	pending
0001144204-14-029158.txt	Edgar Link	pending
0001144204-14-029158-xbrl.zip	Edgar Link	pending
expo-20140404.xml	Edgar Link	completed
expo-20140404.xsd	Edgar Link	pending
expo-20140404_cal.xml	Edgar Link	unprocessable
expo-20140404_def.xml	Edgar Link	unprocessable
expo-20140404_lab.xml	Edgar Link	unprocessable
expo-20140404_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
v376078_10q.htm	Edgar Link	pending
v376078_ex31-1.htm	Edgar Link	pending
v376078_ex31-2.htm	Edgar Link	pending
v376078_ex32-1.htm	Edgar Link	pending
v376078_ex32-2.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$EXPO
EXPONENT INC Stock $expo

2014 Q2 Form 10-Q Financial Statement

#000114420414029158 Filed on May 09, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EXPO EXPONENT INC Stock $expo

2014 Q2 Form 10-Q Financial Statement

#000114420414029158 Filed on May 09, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EXPO
EXPONENT INC Stock $expo